• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

上皮性卵巢癌假阴性腹水细胞学评估:313例患者的研究

Assessment of False-negative Ascites Cytology in Epithelial Ovarian Carcinoma: A Study of 313 Patients.

作者信息

Allen Valerie A, Takashima Yoko, Nayak Seema, Manahan Kelly J, Geisler John P

机构信息

†Division of Gynecologic Oncology *Department of Obstetrics and Gynecology, University of Toledo College of Medicine and Life Sciences, Toledo, OH.

出版信息

Am J Clin Oncol. 2017 Apr;40(2):175-177. doi: 10.1097/COC.0000000000000119.

DOI:10.1097/COC.0000000000000119
PMID:25198110
Abstract

OBJECTIVE

The objective was to determine how often peritoneal cytology is positive for malignancy in women with known ovarian cancer. Knowing this fact would help determine the usefulness of diagnostic paracentesis.

METHODS

Records of all women diagnosed with invasive epithelial ovarian cancer from 2004 to 2012 were examined to correlate presence of ascites, cytologic, and pathologic findings.

RESULTS

A total of 313 patients were included in analysis. A total of 210 of 313 patients (67.1%) with ascites had cytology positive for malignancy. This left 103 patients with ascites and cancer without malignant cells found in the ascites removed at the time of surgery.

CONCLUSIONS

Except in a few cases, paracentesis is not recommended for the diagnosis of ovarian cancer because of the potential spreading of cancer. Furthermore, with only just over two thirds of cases of known cancer and ascites having cytology positive for malignancy, the value of paracentesis for diagnosis of ovarian cancer is minimal.

摘要

目的

本研究旨在确定已知患有卵巢癌的女性中,腹膜细胞学检查恶性肿瘤呈阳性的频率。了解这一情况将有助于确定诊断性腹腔穿刺术的实用性。

方法

对2004年至2012年期间所有被诊断为侵袭性上皮性卵巢癌的女性患者记录进行检查,以关联腹水、细胞学和病理学检查结果。

结果

共有313例患者纳入分析。313例有腹水的患者中,共有210例(67.1%)细胞学检查恶性肿瘤呈阳性。这使得103例有腹水且患有癌症的患者在手术时所抽取的腹水中未发现恶性细胞。

结论

除少数情况外,由于存在癌症扩散的可能性,不建议采用腹腔穿刺术诊断卵巢癌。此外,已知患有癌症且有腹水的病例中,只有略超过三分之二的病例细胞学检查恶性肿瘤呈阳性,因此腹腔穿刺术对卵巢癌的诊断价值极小。

相似文献

1
Assessment of False-negative Ascites Cytology in Epithelial Ovarian Carcinoma: A Study of 313 Patients.上皮性卵巢癌假阴性腹水细胞学评估:313例患者的研究
Am J Clin Oncol. 2017 Apr;40(2):175-177. doi: 10.1097/COC.0000000000000119.
2
The accuracy of ascites cytology in diagnosis of advanced ovarian cancer in postmenopausal women prior to neoadjuvant chemotherapy.绝经后女性新辅助化疗前腹水细胞学检查对晚期卵巢癌的诊断准确性。
Menopause. 2020 Jul;27(7):771-775. doi: 10.1097/GME.0000000000001534.
3
A large-scale multi-institutional study evaluating prognostic aspects of positive ascites cytology and effects of therapeutic interventions in epithelial ovarian cancer.一项评估上皮性卵巢癌阳性腹水细胞学预后方面和治疗干预效果的大规模多机构研究。
Sci Rep. 2021 Jul 26;11(1):15154. doi: 10.1038/s41598-021-93718-3.
4
Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging.明显早期上皮性卵巢癌淋巴结转移的危险因素:对手术分期的影响。
Gynecol Oncol. 2011 Sep;122(3):536-40. doi: 10.1016/j.ygyno.2011.05.001. Epub 2011 Jun 1.
5
Ascites as a predictor of ovarian malignancy.腹水作为卵巢恶性肿瘤的一个预测指标。
Gynecol Oncol. 2002 Oct;87(1):77-83. doi: 10.1006/gyno.2002.6800.
6
A phase II study of aflibercept in patients with advanced epithelial ovarian cancer and symptomatic malignant ascites.一项评估 aflibercept 治疗晚期上皮性卵巢癌合并有症状恶性腹水患者的 II 期临床研究。
Gynecol Oncol. 2012 Apr;125(1):42-7. doi: 10.1016/j.ygyno.2011.11.021. Epub 2011 Nov 21.
7
Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: an NRG Oncology/GOG study.腹水可预测贝伐单抗在晚期上皮性卵巢癌、输卵管癌和腹膜癌一线治疗中的疗效:一项NRG肿瘤学/妇科肿瘤学组研究。
Gynecol Oncol. 2015 Oct;139(1):17-22. doi: 10.1016/j.ygyno.2015.07.103. Epub 2015 Jul 26.
8
Peritoneal catheter site metastasis in a patient with advanced ovarian cancer.晚期卵巢癌患者的腹膜导管部位转移
Am J Hosp Palliat Care. 2012 May;29(3):241-2. doi: 10.1177/1049909111409390. Epub 2011 May 23.
9
EUS-guided paracentesis for the diagnosis of malignant ascites.超声内镜引导下穿刺术用于恶性腹水的诊断。
Gastrointest Endosc. 2006 Dec;64(6):908-13. doi: 10.1016/j.gie.2005.11.058.
10
Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers.腹水中的炎症调节因子作为浆液性上皮性卵巢癌耐药性和无进展生存期的预测生物标志物。
BMC Cancer. 2015 Jul 1;15:492. doi: 10.1186/s12885-015-1511-7.

引用本文的文献

1
A Case Report of Spontaneous Bladder Rupture: An Uncommon Cause of Ascites.一例自发性膀胱破裂病例报告:腹水的罕见病因
Case Rep Oncol. 2025 May 28;18(1):845-855. doi: 10.1159/000546581. eCollection 2025 Jan-Dec.
2
Endoscopic ultrasound-guided tissue acquisition beyond the pancreas.内镜超声引导下胰腺以外组织的获取
Ann Gastroenterol. 2023 May-Jun;36(3):257-266. doi: 10.20524/aog.2023.0797. Epub 2023 Apr 8.
3
Endoscopic ultrasound guided fine needle biopsy (EUS-FNB) from peritoneal lesions: a prospective cohort pilot study.
经内镜超声引导下对腹膜病变进行细针穿刺活检(EUS-FNB):一项前瞻性队列先导研究。
BMC Gastroenterol. 2021 Oct 24;21(1):400. doi: 10.1186/s12876-021-01953-9.
4
Detection of cryptogenic malignancies from metagenomic whole genome sequencing of body fluids.从体液的宏基因组全基因组测序中检测隐匿性恶性肿瘤。
Genome Med. 2021 Jun 1;13(1):98. doi: 10.1186/s13073-021-00912-z.
5
Endoscopic Ultrasound-Guided Random Omental Fine Needle Aspiration: A Novel Technique for the Diagnosis of Peritoneal Carcinomatosis.内镜超声引导下随机大网膜细针穿刺抽吸:一种诊断腹膜癌转移的新技术。
Clin Endosc. 2020 Sep;53(5):594-599. doi: 10.5946/ce.2019.175. Epub 2020 Sep 29.
6
Peritoneal lymphoma with ascites mimicking portal hypertensive ascites: A case report.腹膜淋巴瘤伴腹水酷似门静脉高压性腹水:一例报告
Medicine (Baltimore). 2019 Feb;98(8):e14583. doi: 10.1097/MD.0000000000014583.